China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
WuXi Bio to Sell Vaccine Facility to Merck for $500 Million
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
China's WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million
The Financial Times had reported in October, citing people familiar with the matter, that WuXi and WuXi AppTec are planning ...
WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million
WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...
Merck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeiting
M-Trust is a secure cyber-physical trust platform that enables the creation of digital twins for enhanced product quality and ...
China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
FiercePharma22h
Regulatory tracker: GSK's Nucala cleared for nasal polyps use in China
UPDATED: Friday, Jan. 3 at 2:45 pm ET GSK’s IL-5 inhibitor Nucala scored a nod in China to treat people with ... 1:45pm ET Shortly before the new year, Merck & Co. scored an approval for its ...
DAX Modestly Higher After Data Shows Improvement In Economic Activity
German stocks are modestly higher Monday morning with investors reacting to data on Germany's composite and services sector PMI ...